The chemical class designated as KIAA0319L Inhibitors refers to a range of compounds that act to indirectly influence the activity of KIAA0319L, a protein implicated in neuronal functions and development. These compounds do not directly target KIAA0319L but are thought to affect the cellular and molecular pathways in which KIAA0319L may be involved. This indirect approach is based on modulating various aspects of neuronal processes, including signaling pathways, neurotransmitter dynamics, and other essential cellular mechanisms. The rationale behind this class is to alter the broader biological context within which KIAA0319L operates, impacting its functional role in neuronal cells. The primary mechanism of action of these inhibitors is centered around the modulation of neuronal signaling and communication. By influencing specific neurotransmission pathways or altering the balance of excitatory and inhibitory signals in the brain, these compounds can create changes in the neuronal environment that may indirectly affect the processes regulated by KIAA0319L. This can include alterations in synaptic plasticity, neuronal growth, and differentiation, which are crucial for proper neuronal function and development. Additionally, these inhibitors may target key intracellular signaling cascades that play a role in cellular growth and metabolism, thereby influencing the biological pathways where KIAA0319L is active.
Furthermore, some of these compounds may affect critical developmental signaling pathways or mechanisms involved in protein turnover and cellular metabolism. Such alterations can have cascading effects on neuronal development and maturation, impacting the expression, localization, or functionality of proteins like KIAA0319L. By modifying these pathways, the compounds might indirectly influence the stability, turnover, and overall regulatory role of KIAA0319L in neuronal cells. In summary, KIAA0319L Inhibitors represent a group of compounds that modulate the activity of KIAA0319L through indirect mechanisms. These inhibitors act on various cellular targets, influencing neuronal signaling, development, and other crucial processes. Their indirect mode of action underscores the complexity of targeting specific proteins within intricate cellular networks and highlights the nuanced strategies required to influence protein functionality in the context of broader cellular and molecular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $80.00 $275.00 | ||
A GABA_A receptor antagonist, could influence inhibitory neurotransmission, potentially impacting pathways related to KIAA0319L. | ||||||
D(−)-2-Amino-5-phosphonovaleric acid (D-AP5) | 79055-68-8 | sc-200434 | 5 mg | $95.00 | 2 | |
An NMDA receptor antagonist, could affect glutamatergic signaling, potentially influencing neuronal processes involving KIAA0319L. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor, could affect a variety of signaling pathways, potentially including those involving KIAA0319L. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor, could indirectly impact signaling pathways relevant to KIAA0319L. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
A calcium channel blocker, could affect calcium signaling in neurons, potentially influencing KIAA0319L-related processes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects GSK-3 and Wnt signaling, potentially influencing developmental pathways relevant to KIAA0319L. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
A compound with various cellular effects, could influence signaling pathways potentially relevant to KIAA0319L. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, could influence neuronal growth and development, potentially impacting KIAA0319L. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Inhibits the Hedgehog signaling pathway, potentially affecting developmental processes relevant to KIAA0319L. | ||||||